Genetic and epigenetic inactivation of Kruppel-like Factor 4 in medulloblastoma

Neoplasia

Volumn 12, Issue 1, 2010, Pages 20-27

  Nakahara, Yukiko ^a   Northcott, Paul A ^a,b   Li, Meihua ^a   Kongkham, Paul N ^a,b   Smith, Christian ^a   Yan, Hai ^c   Croul, Sidney ^d   Ra, Young Shin ^a   Eberhart, Charles ^e   Huang, Annie ^a   Bigner, Darrell ^c   Grajkowska, Wesia ^f   Van Meter, Timothy ^g   Rutka, James T ^a,b   Taylor, Michael D ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BISULFITE; KRUPPEL LIKE FACTOR 4; PROTEIN; RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE SEQUENCE; GENE TARGETING; GENETICS; GROWTH INHIBITION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPING; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 73949114835     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.91122     Document Type: Article

References (39)

1. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, et al. (2006). Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7, 813-820.
2. De Smaele E, Fragomeli C, Ferretti E, Pelloni M, Po A, Canettieri G, Coni S, Di Marcotullio L, Greco A, Moretti M, et al. (2008). An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma. Neoplasia 10, 89-98.
3. Gershon TR, Oppenheimer O, Chin SS, and Gerald WL (2005). Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia 7, 575-584.
4. Kim DS, Hubbard SL, Peraud A, Salhia B, Sakai K, and Rutka JT (2004). Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia 6, 168-178.
5. Michael LE, Westerman BA, Ermilov AN, Wang A, Ferris J, Liu J, Blom M, Ellison DW, van Lohuizen M, and Dlugosz AA (2008). Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion. Neoplasia 10, 1343-1349; 1345p following 1349.
6. Raffel C (2004). Medulloblastoma: molecular genetics and animal models. Neoplasia 6, 310-322.
7. Rao G, Pedone CA, Coffin CM, Holland EC, and Fults DW (2003). c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 5, 198-204.
8. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY, and Liu J (2008). Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10, 736-744.
9. Zhang Y, Laterra J, and Pomper MG (2009). Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia 11, 96-101.
10. Tamber MS, Bansal K, Liang ML, Mainprize TG, Salhia B, Northcott P, Taylor M, and Rutka JT (2006). Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies. Childs Nerv Syst 22, 1379-1394.
11. Wei D, Kanai M, Jia Z, Le X, and Xie K (2008). Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 68, 4631-4639.
12. Yasunaga J, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, Sakai T, Mitsuya H, and Matsuoka M (2004). Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 64, 6002-6009.
13. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, and Yang VW (2004). Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23, 395-402.
14. Rowland BD and Peeper DS (2006). KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6, 11-23.
15. Rowland BD, Bernards R, and Peeper DS (2005). The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7, 1074-1082.
16. Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, et al. (2004). Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 10, 2709-2719.
17. Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH, and Yang VW (2007). Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 67, 7147-7154.
18. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et al. (2009). Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41 (4), 465-472.
19. Northcott PA, Fernandez LA, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, VanMeter T, Rutka JT, Croce CM, et al. (2009). The miR-17/92 polycistron is up-regulated in Sonic Hedgehog-driven medulloblastomas and induced by N-myc in Sonic Hedgehog-treated cerebellar neural precursors. Cancer Res 69 (8), 3249-3255.
20. Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C, Cummins JM, Velculescu VE, Fults DW, et al. (2005). Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 65, 919-924.
21. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et al. (2009). Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41, 465-472.
22. Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE, Smith CA, Taylor MD, and Rutka JT (2008). An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 68, 9945-9953.
23. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjoblom T, Park BH, Parsons R, et al. (2008). Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 105, 16224-16229.
24. Varshavsky A (2007). Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy. Proc Natl Acad Sci USA 104, 14935-14940.
25. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P, Davies H, Watt S, Teague J, Edkins S, et al. (2005). A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci USA 102, 4542-4547.
26. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, and Xie K (2005). Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65, 2746-2754.
27. Anderton JA, Lindsey JC, Lusher ME, Gilbertson RJ, Bailey S, Ellison DW, and Clifford SC (2008). Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2. Neuro Oncol 10, 981-994.
28. Lindsey JC, Lusher ME, Anderton JA, Gilbertson RJ, Ellison DW, and Clifford SC (2007). Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma. Br J Cancer 97, 267-274.
29. Stratton MR, Campbell PJ, and Futreal PA (2009). The cancer genome. Nature 458, 719-724.
30. Kip1 and patched-1, collaborate to prevent medulloblastoma. Mol Cancer Res 7, 33-40.
31. Kip1 coordinately regulate cerebellar development. Proc Natl Acad Sci USA 103, 11579-11583.
32. Klaewsongkram J, Yang Y, Golech S, Katz J, Kaestner KH, and Weng NP (2007). Kruppel-like factor 4 regulates B cell number and activation-induced B cell proliferation. J Immunol 179, 4679-4684.
33. Huard JM, Forster CC, Carter ML, Sicinski P, and Ross ME (1999). Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development 126, 1927-1935.
34. Yokota N, Mainprize TG, Taylor MD, Kohata T, Loreto M, Ueda S, Dura W, Grajkowska W, Kuo JS, and Rutka JT (2004). Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene 23, 3444-3453.
35. Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, and Eberhart CG (2004). Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64, 7787-7793.
36. Solecki DJ, Liu XL, Tomoda T, Fang Y, and Hatten ME (2001). Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 31, 557-568.
37. Zheng H, Pritchard DM, Yang X, Bennett E, Liu G, Liu C, and Ai W (2009). KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. Am J Physiol 296, G490-G498.
38. Taylor MD, Zhang X, Liu L, Hui CC, Mainprize TG, Scherer SW, Wainwright B, Hogg D, and Rutka JT (2004). Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling. Oncogene 23, 4577-4583.
39. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, et al. (2006). Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24, 1924-1931.